ATE119541T1 - Verfahren zur herstellung von nucleosiden und ihre analogen. - Google Patents

Verfahren zur herstellung von nucleosiden und ihre analogen.

Info

Publication number
ATE119541T1
ATE119541T1 AT91906244T AT91906244T ATE119541T1 AT E119541 T1 ATE119541 T1 AT E119541T1 AT 91906244 T AT91906244 T AT 91906244T AT 91906244 T AT91906244 T AT 91906244T AT E119541 T1 ATE119541 T1 AT E119541T1
Authority
AT
Austria
Prior art keywords
nucleoside
analogues
cyclonucleoside
cytarabine
amine
Prior art date
Application number
AT91906244T
Other languages
English (en)
Inventor
Khashayar Karimian
Original Assignee
Acic Canada Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CA 2012093 external-priority patent/CA2012093C/en
Priority claimed from CA 2012094 external-priority patent/CA2012094C/en
Application filed by Acic Canada Inc filed Critical Acic Canada Inc
Application granted granted Critical
Publication of ATE119541T1 publication Critical patent/ATE119541T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H23/00Compounds containing boron, silicon or a metal, e.g. chelates or vitamin B12
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06Pyrimidine radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT91906244T 1990-03-13 1991-03-13 Verfahren zur herstellung von nucleosiden und ihre analogen. ATE119541T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA 2012093 CA2012093C (en) 1990-03-13 1990-03-13 Process for producing 2,2'-cyclocytidine and analogues thereof
CA 2012094 CA2012094C (en) 1990-03-13 1990-03-13 Process for producing cytarabine and analogues thereof

Publications (1)

Publication Number Publication Date
ATE119541T1 true ATE119541T1 (de) 1995-03-15

Family

ID=25674007

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91906244T ATE119541T1 (de) 1990-03-13 1991-03-13 Verfahren zur herstellung von nucleosiden und ihre analogen.

Country Status (8)

Country Link
US (1) US5610292A (de)
EP (1) EP0521923B1 (de)
AT (1) ATE119541T1 (de)
AU (1) AU7473791A (de)
BR (1) BR9106158A (de)
DE (1) DE69108014T2 (de)
HU (1) HUT61566A (de)
WO (1) WO1991013900A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2192950A1 (en) * 1994-06-22 1995-12-28 Danny P.C. Mcgee Novel method of preparation of known and novel 2'-modified nucleosides by intramolecular nucleophilic displacement
IT1277425B1 (it) 1995-08-03 1997-11-10 Pro Bio Sint Srl Metodo per la preparazione della 1-b-d-arabinofuranosilcitosina
CA2277159A1 (en) 1997-01-08 1998-07-16 Wolfgang Pieken Bioconjugation of macromolecules
US7427678B2 (en) 1998-01-08 2008-09-23 Sigma-Aldrich Co. Method for immobilizing oligonucleotides employing the cycloaddition bioconjugation method
WO2001079248A1 (fr) * 2000-04-13 2001-10-25 Mitsui Chemicals, Inc. Procede de preparation de derives de cytidine
WO2003009815A2 (en) 2001-07-25 2003-02-06 Biomarin Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
AU2003210629A1 (en) 2002-01-23 2003-09-02 Proligo, Llc Methods for the integrated synthesis and purification of oligonucleotides
JP4791043B2 (ja) 2002-12-31 2011-10-12 プロリゴ・エルエルシー 同一固体支持体上で、2以上のオリゴヌクレオチドをタンデムに合成するための方法および組成物
WO2005026186A1 (de) * 2003-09-12 2005-03-24 Max-Delbrück-Centrum für Molekulare Medizin Β-l-nucleoside und ihre verwendung als pharmazeutische mittel zur behandlung viraler erkrankungen
CN1300326C (zh) * 2004-12-22 2007-02-14 华南理工大学 酶催化制备阿糖胞苷酯的方法
SI1889198T1 (sl) 2005-04-28 2015-02-27 Proteus Digital Health, Inc. Farma-informacijski sistem
EP2063905B1 (de) 2006-09-18 2014-07-30 Raptor Pharmaceutical Inc Behandlungen von lebererkrankungen durch verabreichung von konjugaten aus rezeptor-assoziierten proteinen
US8404830B2 (en) 2007-07-17 2013-03-26 Somalogic, Inc. Method for generating aptamers with improved off-rates
JP5504179B2 (ja) 2008-03-03 2014-05-28 トスク インコーポレーティッド 毒性を低減するためのメトトレキセートアジュバントおよびその使用法
DK2398500T3 (da) 2009-02-20 2019-05-13 2 Bbb Medicines B V Glutathion-baseret lægemiddelafgivelsessystem
SG175896A1 (en) 2009-05-06 2011-12-29 Lab Skin Care Inc Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
CA2793451A1 (en) 2010-04-12 2011-10-20 Somalogic, Inc. Aptamers to .beta.-ngf and their use in treating .beta.-ngf mediated diseases and disorders
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
RU2732402C2 (ru) 2013-11-21 2020-09-16 Сомалоджик, Инк. Цитидин-5-карбоксамид модифицированные нуклеотидные композиции и способы, относящиеся к ним
US11446303B2 (en) 2019-06-21 2022-09-20 Tosk, Inc. Uridine phosphorylase (UPase) inhibitors for treatment of liver conditions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4652554A (en) * 1982-02-22 1987-03-24 St. Jude Children's Research Hospital Nitro-substituted 1-β-D-arabinofuranosylcytosines
EP0523080B1 (de) * 1990-03-13 1995-07-19 Acic (Canada) Inc. 2,3'-o-cyclocytidine und verfahren zu deren herstellung

Also Published As

Publication number Publication date
WO1991013900A1 (en) 1991-09-19
DE69108014D1 (de) 1995-04-13
US5610292A (en) 1997-03-11
HUT61566A (en) 1993-01-28
DE69108014T2 (de) 1995-07-06
HU9202906D0 (en) 1992-11-30
EP0521923A1 (de) 1993-01-13
BR9106158A (pt) 1993-03-16
EP0521923B1 (de) 1995-03-08
AU7473791A (en) 1991-10-10

Similar Documents

Publication Publication Date Title
ATE119541T1 (de) Verfahren zur herstellung von nucleosiden und ihre analogen.
ATE237613T1 (de) Verfahren für die herstellung von antiviralen substituierten 1, 3-oxathiolanen
DE69132318D1 (de) Verfahren zur herstellung von pyrimidinverbindungen
EP0236935A3 (de) Carbozyklische Purinnukleoside, ihre Herstellung und Anwendung
AT380252B (de) Verfahren zur herstellung von neuen guanin- und 2,6-diaminopurinderivaten und ihren salzen
DE68901153D1 (de) Derivate von purin, verfahren zu ihrer herstellung und pharmazeutische zubereitung.
DE3762615D1 (de) Verfahren zur herstellung von (2,2)-paracyclophan und dessen derivaten.
ATE198479T1 (de) Verfahren zur herstellung von purinderivaten
DE3574472D1 (de) Verfahren zur herstellung von 2'-desoxyadenosinverbindungen.
SE7910376L (sv) Kinazolinonderivat
AT368156B (de) Verfahren zur herstellung von neuen 4-oxo-4hpyrido(1,2-a)pyrimidinderivaten sowie von deren saeureadditions- oder quaternaeren salzen
DE3788921D1 (de) Verfahren zur Herstellung von 5-Methyltetrazol.
ATE287879T1 (de) Verfahren zur herstellung von isoflavonen
ATE199724T1 (de) Verfahren zur herstellung von 1-(2'-desoxy-2',2'- difluoro-d-ribo-pentofuranosyl)-cytosin aus 2- desoxy-2,2-difluoro-beta-d-ribo-pentopyranose
ATE58532T1 (de) (2-amino-4-aryl-thiazol-5-yl)aethanol, und deren derivate mit diuretischer aktivitaet und verfahren zu deren herstellung.
DE69404953D1 (de) Verfahren zur Herstellung von AZT und Derivaten davon
DE69627519D1 (de) Sesquiterpen-derivate mit antiviraler aktivität
DE69129971D1 (de) Verfahren zur herstellung von 9-beta-d-arabinofuranosyl-2-fluoroadenin 5'-phosphaten
ATE213734T1 (de) Verfahren zur herstellung von 1,3- disubstituierten 2-nitroguanidinen
CA2012094A1 (en) Process for producing cytarabine and analogues thereof
DE3777464D1 (de) Fluorine enthaltende vitamin-d3-derivate und verfahren zu ihrer herstellung.
CA2012093A1 (en) Process for producing 2,2'-cyclocytidine and analogues thereof
DE69809205D1 (de) Verfahren zur herstellung von azyklischen nukleosiden
ATE156824T1 (de) Verfahren zur herstellung von pyrido(1,2- a>pyrimidinderivaten
ATE111093T1 (de) Verfahren zur herstellung von enantiomeren von 3- aminchromanderivaten.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties